Nu-Med Plus, Inc.
NUMD
$0.06
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -47.47% | 52.65% | -6.55% | -23.58% | -33.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -47.47% | 52.65% | -6.63% | -23.73% | -33.90% |
| Operating Income | 47.47% | -52.65% | 6.63% | 23.73% | 33.90% |
| Income Before Tax | 45.50% | -334.98% | -64.85% | -16.99% | 3.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.50% | -334.98% | -64.85% | -16.99% | 3.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.50% | -334.98% | -64.85% | -16.99% | 3.68% |
| EBIT | 47.47% | -52.65% | 6.63% | 23.73% | 33.90% |
| EBITDA | -- | 21.60% | 38.75% | 38.20% | 34.24% |
| EPS Basic | 46.67% | -366.67% | -75.00% | -25.00% | 6.25% |
| Normalized Basic EPS | 44.44% | -33.33% | 20.00% | 30.77% | 43.75% |
| EPS Diluted | 46.67% | -366.67% | -75.00% | -25.00% | 6.25% |
| Normalized Diluted EPS | 44.44% | -33.33% | 20.00% | 30.77% | 43.75% |
| Average Basic Shares Outstanding | 2.97% | 1.07% | 1.57% | 2.20% | 2.16% |
| Average Diluted Shares Outstanding | 2.97% | 1.07% | 1.57% | 2.20% | 2.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |